Kiora Pharmaceuticals, Inc.

( )
EYEG After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. 0.00%45.880.0%$167.43m
VRXValeant Pharmaceuticals International, Inc. -0.04%27.0714.1%$159.28m
ICLRICON plc 0.00%266.392.8%$142.73m
CTLTCatalent, Inc. -0.05%108.192.0%$117.41m
BHCBausch Health Cos., Inc. -0.04%27.070.0%$112.90m
HZNPHorizon Therapeutics Plc 0.00%91.105.4%$106.55m
JAZZJazz Pharmaceuticals Plc 0.00%144.302.1%$88.31m
UTHRUnited Therapeutics Corp. 0.00%213.9613.9%$83.03m
ARGXargenx SE 0.00%291.500.0%$68.34m
PRGOPerrigo Co. Plc 0.03%39.746.9%$50.64m
BRBRBellRing Brands, Inc. 0.04%25.930.0%$28.46m
PCRXPacira Biosciences, Inc. 0.00%64.089.8%$26.06m
CORTCorcept Therapeutics, Inc. 0.00%18.455.5%$21.72m
SAGESAGE Therapeutics, Inc. 0.00%42.937.6%$19.98m
IRWDIronwood Pharmaceuticals, Inc. 0.00%11.729.5%$19.47m

Company Profile

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.